
("Caledonian" or "the Company")
Update on Proposed Fundraising
The Board of
As previously detailed, the purpose of the Proposed Fundraising is for the Company to raise further funds to invest directly into
In order to prioritise engagement with certain institutional investors and providers of structured capital solutions, the Company, in conjunction with its advisers, has decided to step back at this stage from a wider marketing of the Proposed Fundraising. Whilst the Company has been introduced to a number of traditional public market investors as part of the Proposed Fundraising, the Board believes that at this stage, discussions focusing on institutional counterparties are better aligned with the Company's immediate objectives.
Should terms with such institutional or other parties be agreed in the near future, the Company would give consideration to re-engaging with the other public market investors met during the Proposed Fundraising, to provide them with the opportunity to participate on the same terms where practicable. This approach is intended to balance institutional support with access for retail investors.
As indicated, Caledonian continues to hold constructive discussions with a number of significant funding sources which, should these be concluded, would enable the Company to make a further significant investment into AlbaCo and continue to progress its wider financial services investment strategy.
The Board remains confident in its ability to secure the additional capital required and will provide further updates as appropriate.
Capitalised terms used in this announcement shall have the same meaning as in the announcement of
For further information, please contact:
|
Tel: +44 (0) 7950 389469 |
|
Tel: +44 (0) 20 3328 5656 |
|
|
|
Tel: +44 (0) 20 7469 0930 |
|
|
|
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the